|
2021 Journal Article Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammationNiyonzima, Nathalie, Rahman, Jubayer, Kunz, Natalia, West, Erin E., Freiwald, Tilo, Desai, Jigar V., Merle, Nicolas S., Gidon, Alexandre, Sporsheim, Bjørnar, Lionakis, Michail S., Evensen, Kristin, Lindberg, Beate, Skagen, Karolina, Skjelland, Mona, Singh, Parul, Haug, Markus, Ruseva, Marieta M., Kolev, Martin, Bibby, Jack, Marshall, Olivia, O’Brien, Brett, Deeks, Nigel, Afzali, Behdad, Clark, Richard J., Woodruff, Trent M., Pryor, Milton, Yang, Zhi-Hong, Remaley, Alan T., Mollnes, Tom E. ... Kemper, Claudia (2021). Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation. Science Immunology, 6 (66) eabf2489, eabf2489. doi: 10.1126/sciimmunol.abf2489 |
|
2021 Journal Article In vivo pharmacodynamic method to assess complement C5a receptor antagonist efficacyCui, Cedric S., Kumar, Vinod, Gorman, Declan M., Clark, Richard J., Lee, John D. and Woodruff, Trent M. (2021). In vivo pharmacodynamic method to assess complement C5a receptor antagonist efficacy. ACS Pharmacology and Translational Science, 5 (1) acsptsci.1c00227, 41-51. doi: 10.1021/acsptsci.1c00227 |
|
2021 Conference Publication An in-vivo pharmacodynamic method to investigate complement C5a receptor antagonistsCui, Cedric, Kumar, Vinod, Gorman, Declan, Clark, Richard, Lee, John and Woodruff, Trent (2021). An in-vivo pharmacodynamic method to investigate complement C5a receptor antagonists. ICW – 2021 Virtual Workshop of the International Complement Society (ICS), Virtual, 7-10 December 2021. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.molimm.2021.11.020 |
|
2021 Journal Article Unexpected off-target activities for recombinant C5a in human macrophagesLi, Xaria X., Gorman, Declan M., Lee, John D., Clark, Richard J. and Woodruff, Trent M. (2021). Unexpected off-target activities for recombinant C5a in human macrophages. Journal of Immunology, 208 (1), 133-142. doi: 10.4049/jimmunol.2100444 |
|
2021 Journal Article Solution NMR and racemic crystallography provide insights into a novel structural class of cyclic plant peptidesPayne, Colton D., Vadlamani, Grishma, Hajiaghaalipour, Fatemeh, Muhammad, Taj, Fisher, Mark F., Andersson, Håkan S., Göransson, Ulf, Clark, Richard J., Bond, Charles S., Mylne, Joshua S. and Rosengren, K. Johan (2021). Solution NMR and racemic crystallography provide insights into a novel structural class of cyclic plant peptides. RSC Chemical Biology, 2 (6), 1682-1691. doi: 10.1039/d1cb00155h |
|
2021 Journal Article Biostimulation of bacteria in liquid culture for identification of new antimicrobial compoundsMirzaee, Hooman, Ariens, Emily, Blaskovich, Mark A. T., Clark, Richard J. and Schenk, Peer M. (2021). Biostimulation of bacteria in liquid culture for identification of new antimicrobial compounds. Pharmaceuticals, 14 (12) 1232, 1232. doi: 10.3390/ph14121232 |
|
2021 Journal Article A conserved β‐bulge glycine residue facilitates folding and increases stability of the mouse α‐defensin cryptdin‐4Clark, Richard J., Phan, Thanh Huyen, Song, Angela, Ouellette, André J., Conibear, Anne C. and Rosengren, K. Johan (2021). A conserved β‐bulge glycine residue facilitates folding and increases stability of the mouse α‐defensin cryptdin‐4. Peptide Science, 114 (1) e24250. doi: 10.1002/pep2.24250 |
|
2021 Journal Article Development of synthetic human and mouse C5a: application to binding and functional assays in vitro and in vivoGorman, Declan M., Li, Xaria X., Payne, Colton D., Cui, Cedric S., Lee, John D., Rosengren, K. Johan, Woodruff, Trent M. and Clark, Richard J. (2021). Development of synthetic human and mouse C5a: application to binding and functional assays in vitro and in vivo. ACS Pharmacology and Translational Science, 4 (6) acsptsci.1c00199, 1808-1817. doi: 10.1021/acsptsci.1c00199 |
|
2021 Journal Article Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo ActivityGorman, Declan M., Li, Xaria X., Lee, John D., Fung, Jenny N., Cui, Cedric S., Lee, Han Siean, Rolfe, Barbara E., Woodruff, Trent M. and Clark, Richard J. (2021). Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity. Journal of Medicinal Chemistry, 64 (22) acs.jmedchem.1c01174, 16598-16608. doi: 10.1021/acs.jmedchem.1c01174 |
|
2021 Journal Article Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonistsLi, Xaria X., Clark, Richard J. and Woodruff, Trent M. (2021). Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists. International Immunopharmacology, 100 108074, 108074. doi: 10.1016/j.intimp.2021.108074 |
|
2021 Journal Article LEAP-2: an emerging endogenous ghrelin receptor antagonist in the pathophysiology of obesityLu, Xuehan, Huang, Lili, Huang, Zhengxiang, Feng, Dandan, Clark, Richard J. and Chen, Chen (2021). LEAP-2: an emerging endogenous ghrelin receptor antagonist in the pathophysiology of obesity. Frontiers in Endocrinology, 12 717544, 717544. doi: 10.3389/fendo.2021.717544 |
|
2021 Journal Article Synthetic hookworm-derived peptides are potent modulators of primary human immune cell function that protect against experimental colitis in vivoSmallwood, Taylor B., Navarro, Severine, Cristofori-Armstrong, Ben, Watkins, Thomas S., Tungatt, Katie, Ryan, Rachael Y.M., Haigh, Oscar L., Lutzky, Viviana P., Mulvenna, Jason P., Rosengren, K. Johan, Loukas, Alex, Miles, John J. and Clark, Richard J. (2021). Synthetic hookworm-derived peptides are potent modulators of primary human immune cell function that protect against experimental colitis in vivo. Journal of Biological Chemistry, 297 (1) 100834, 1-14. doi: 10.1016/j.jbc.2021.100834 |
|
2021 Journal Article Design of a stable cyclic peptide analgesic derived from sunflower seeds that targets the κ-opioid receptor for the treatment of chronic abdominal painMuratspahić, Edin, Tomašević, Nataša, Koehbach, Johannes, Duerrauer, Leopold, Hadžić, Seid, Castro, Joel, Schober, Gudrun, Sideromenos, Spyridon, Clark, Richard J., Brierley, Stuart M., Craik, David J. and Gruber, Christian W. (2021). Design of a stable cyclic peptide analgesic derived from sunflower seeds that targets the κ-opioid receptor for the treatment of chronic abdominal pain. Journal of Medicinal Chemistry, 64 (13) acs.jmedchem.1c00158, 9042-9055. doi: 10.1021/acs.jmedchem.1c00158 |
|
2021 Journal Article Effects of backbone cyclization on the pharmacokinetics and drug efficiency of the orally active analgesic conotoxin cVc1.1Poth, Aaron G., Chiu, Francis C.K., Stalmans, Sofie, Hamilton, Brett R., Huang, Yen-Hua, Shackleford, David M., Patil, Rahul, Le, Thao T., Kan, Meng-Wei, Durek, Thomas, Wynendaele, Evelien, De Spiegeleer, Bart, Powell, Andrew K., Venter, Deon J., Clark, Richard J., Charman, Susan A. and Craik, David J. (2021). Effects of backbone cyclization on the pharmacokinetics and drug efficiency of the orally active analgesic conotoxin cVc1.1. Medicine in Drug Discovery, 10 100087, 1-10. doi: 10.1016/j.medidd.2021.100087 |
|
2021 Journal Article Advances in venom peptide drug discovery: where are we at and where are we heading?Smallwood, Taylor B. and Clark, Richard J. (2021). Advances in venom peptide drug discovery: where are we at and where are we heading?. Expert Opinion on Drug Discovery, 16 (10) 17460441.2021.1922386, 1-11. doi: 10.1080/17460441.2021.1922386 |
|
2021 Journal Article A chameleonic macrocyclic peptide with drug delivery applicationsPayne, Colton D., Franke, Bastian, Fisher, Mark F., Hajiaghaalipour, Fatemeh, McAleese, Courtney E., Song, Angela, Eliasson, Carl, Zhang, Jingjing, Jayasena, Achala S., Vadlamani, Grishma, Clark, Richard J., Minchin, Rodney F., Mylne, Joshua S. and Rosengren, K. Johan (2021). A chameleonic macrocyclic peptide with drug delivery applications. Chemical Science, 12 (19), 6670-6683. doi: 10.1039/d1sc00692d |
|
2021 Journal Article ERK and mTORC1 inhibitors enhance the anti-cancer capacity of the octpep-1 venom-derived peptide in melanoma BRAF(V600E) mutationsMoral-Sanz, Javier, Fernandez-Rojo, Manuel A., Potriquet, Jeremy, Mukhopadhyay, Pamela, Brust, Andreas, Wilhelm, Patrick, Smallwood, Taylor B., Clark, Richard J., Fry, Bryan G., Alewood, Paul F., Waddell, Nicola, Miles, John J., Mulvenna, Jason P. and Ikonomopoulou, Maria P. (2021). ERK and mTORC1 inhibitors enhance the anti-cancer capacity of the octpep-1 venom-derived peptide in melanoma BRAF(V600E) mutations. Toxins, 13 (2) 146, 1-19. doi: 10.3390/toxins13020146 |
|
2021 Journal Article Pursuing orally bioavailable hepcidin analogues via cyclic N-methylated mini-hepcidinsGoncalves Monteiro, Daniela, van Dijk, Johannes W. A., Aliyanto, Randy, Fung, Eileen, Nemeth, Elizabeta, Ganz, Tomas, Rosengren, Johan and Clark, Richard J. (2021). Pursuing orally bioavailable hepcidin analogues via cyclic N-methylated mini-hepcidins. Biomedicines, 9 (2) 164, 1-14. doi: 10.3390/biomedicines9020164 |
|
2021 Journal Article The “C3aR Antagonist” SB290157 is a partial C5aR2 agonistLi, Xaria X., Kumar, Vinod, Clark, Richard J., Lee, John D. and Woodruff, Trent M. (2021). The “C3aR Antagonist” SB290157 is a partial C5aR2 agonist. Frontiers in Pharmacology, 11 591398, 591398. doi: 10.3389/fphar.2020.591398 |
|
2021 Journal Article Chemical synthesis and characterisation of the complement C5 inhibitory peptide zilucoplanGorman, Declan M., Lee, John, Payne, Colton D., Woodruff, Trent M. and Clark, Richard J. (2021). Chemical synthesis and characterisation of the complement C5 inhibitory peptide zilucoplan. Amino Acids, 53 (1), 143-147. doi: 10.1007/s00726-020-02921-5 |
